| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $34.6M | +11.8% |
| SG&A Expense | $13.5M | +19.9% |
| Operating Income | -$48.2M | -14.0% |
| Pre-tax Income | -$46.0M | -9.3% |
| Net Income | -$46.1M | -9.3% |
| EPS (Basic) | -$1.31 | +39.4% |
| EPS (Diluted) | -$1.31 | +39.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $147.1M | -22.5% |
| Current Assets | $149.2M | -22.7% |
| Total Assets | $153.2M | -21.6% |
| Current Liabilities | $5.3M | -29.2% |
| Total Liabilities | $6.9M | -14.2% |
| Stockholders' Equity | $146.3M | -21.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$42.5M | -18.0% |
| Capital Expenditures | $312K | -73.8% |
| Investing Cash Flow | -$312K | +73.8% |
| Financing Cash Flow | $242K | -99.9% |
| Free Cash Flow | -$42.8M | -15.1% |